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To the Editor: Community-asso-
ciated methicillin-resistant Staphylo-
coccus aureus (CA-MRSA) is an
emerging phenomenon that has been
reported from almost every continent
in the world (1–4). Such strains are
usually characterized by multisuscep-
tibility to non-β-lactam antimicrobial
drugs, production of Panton-Valentine
leukocidin (PVL), and presence of
staphylococcal chromosome cassette
mec (SCCmec) IVa, a novel smaller
variant of the methicillin-resistance
locus (5). The genetic backgrounds of
CA-MRSA strains from different
parts of the world are distinct and spe-
cific for each geographic region
(1–5). 
We conducted a study at our insti-
tution, a 1,600-bed adult acute-care,
tertiary-level public hospital, to deter-
mine evidence and the clinical and
molecular profile of CA-MRSA in
Singapore. We reviewed the microbi-
ology laboratory records at our institu-
tion for multidrug-susceptible MRSA
strains isolated from January 1, 2001,
to April 15, 2004. S. aureus was iden-
tified by colony morphologic features,
coagulation of citrated rabbit plasma
with EDTA (BBL Becton Dickinson
and Co., Cockeysville, MD, USA),
and production of clumping factor and
protein A(BactiStaph, Remel, Lenexa,
KS, USA). Methicillin resistance was
determined by susceptibility testing
and confirmed by latex agglutination
for penicillin binding protein-2a (6).
Multidrug-susceptible strains were
defined by susceptibility to cotrimoxa-
zole and gentamicin as determined by
the Kirby-Bauer disk diffusion method
following NCCLS guidelines (7).
The medical records of patients
infected by these MRSA were
reviewed, and strains were labeled
community-associated if they had
been isolated within 48 hours of hos-
pitalization from patients who had not
been in any hospital for >1 year.
Community-associated strains were
tested for PVL genes (8), and the
SCCmec  was typed by following a
previously described method (9).
Molecular typing was done by pulsed-
field gel electrophoresis (PFGE) with
restriction endonuclease SmaI and
multilocus sequence typing (10).
These strains were sent to the French
Reference Center for Staphylococci,
where genetic sequences encoding
accessory gene regulator (agr) sub-
types, enterotoxins, exfoliative toxins,
toxic-shock syndrome toxin-1,
hemolysins, and LukE-LukD leuko-
toxin were detected by polymerase
chain reaction (PCR)–based methods.
Comparisons with CA-MRSA strains
worldwide in terms of toxin profile
and PFGE patterns were also per-
formed in France; the latter was
achieved by using Taxotron software
(Institut Pasteur, Paris, France) to dig-
itize and analyze SmaI macrorestric-
tion patterns. 
Eight of 266 multidrug-susceptible
strains fulfilled the criteria for com-
munity acquisition, but only 5 of these
strains (corresponding to patients 1, 3,
and 6–8) had been archived. The
demographic and clinical data of the
patients are shown in the Table. Most
were young, healthy adults with cuta-
neous abscesses. Patient 1 had dia-
betes mellitus but had never been hos-
pitalized; he was the only patient with
severe bacteremic pneumonia. Patient
6 had early-stage endometrial cancer
resected in 2000 but had not attended
her follow-up appointments for >1
year before her hospitalization.
Patient 8 had traveled to Taipei,LETTERS
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Taiwan, for a month; the abscess
developed 3 days after her return
home. Travel history was not docu-
mented in the other patients’ records.
Patients 2–8 received β-lactam
antimicrobial drugs in addition to sur-
gical drainage of their abscesses and
recovered without any complications. 
All 5 archived strains had different
molecular and toxin profiles, and the
only consistent feature was the pres-
ence of PVL genes. Isolates 3 and 7
possessed SCCmec IV. Isolates 1, 6,
and 8 were mecA positive, but their
SCCmec  belonged to none of the 4
major structural types. Comparisons
with published data on CA-MRSA
strains showed that isolate 7 was iden-
tical to the European strain of CA-
MRSA in terms of PFGE pattern,
toxin profile, and sequence type (ST
80) (2,5). Isolate 3 had an identical
PFGE pattern and sequence type (ST
30) compared to the Oceanian
Southwest Pacific strain but differed
slightly in toxin profile, as the LukD-
LukE leukocidin genes were absent
(3,5). Isolate 8 was similar to the
Taiwanese strains: it was ST 59 and
had non-typable SCCmec (4). It
belonged to agr 1 and tested positive
for enterotoxin sek, γ2-hemolysin, and
β-hemolysin genes. 
Isolate 6 had a PFGE pattern that
may be distantly related to U.S.
strains; the similar sequence type
(ST 1) served to emphasize this,
although the presence of nontypable
SCCmec rather than SCCmec  IV
implied that methicillin resistance
was acquired differently. It belonged
to agr 3 and tested positive for
LukD-LukE leukocidin, enterotoxins
seb and seh, and γ2-hemolysin genes.
Isolate 1 is unique to Singapore in that
it had a novel sequence type (ST524:
7-6-1-5-71-5-6 and SCCmec. It
belonged to agr 1 and tested positive
for γ-hemolysin gene as well as for
the enterotoxin gene cluster.
Widely diversified CA-MRSA
strains exist in Singapore. The demo-
graphic profile and clinical symptoms
of local patients infected with these
strains were consistent with published
literature (2–4). The lack of a pediatric
unit at our institution prevented a more
complete epidemiologic description.
In contrast to previous reports
(1–5), our findings are unique in that
most of our strains do not have a dis-
tinctive molecular profile and may be
related to strains from different parts
of the world. Epidemiologic and
molecular data strongly suggest that
isolate 8 was imported from Taiwan.
Some of the other strains (especially
isolates 3 and 7) may have been
imported from other countries too, as
Singapore is an international travel
hub with >6 million visitors annually. 
CA-MRSA has only been isolated
sporadically in Singapore, and no
dominant clone was seen among our
isolates. Singapore may be in an early
phase of CA-MRSA emergence, and
healthcare workers should remain
vigilant for future outbreaks. 
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